If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

What’s in a name? Well, JJ Spaun’s dramatic win in the US Open – where he used his putter like a magic wand, especially his ...

Presentation underscores unique potential for atrioventricular interval modulation ("AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction ...

Researchers at MUSC Hollings Cancer Center are working to pursue better options for people with treatment-resistant cancer.

The good times keep rolling for the Charlestown Sarsfields underage age academies with the club's under-14 boys team ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

A big score went begging for Warner, who was playing catch-up all day after giving away three early free kicks. He finished ...

Nirogacestat exhibited a manageable safety and tolerability profile. The most common adverse reactions reported in patients receiving nirogacestat were diarrhea, ovarian toxicity, rash, nausea, ...

Charlestown Sarsfields captured back-to-back Division 2 Mayo League titles with a splendid 2-11 to 1-7 victory over ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the ped ...